Back to 
Russell Investments Group, Ltd.
Russell Investments Group, Ltd.
VVOS
Showing 0 of 6 quarters
Position history for Russell Investments Group, Ltd.'s holdings in Vivos Therapeutics, Inc.
No. Russell Investments Group exited its VVOS (Vivos Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 365,901 shares worth $236,000. Russell Investments Group first reported VVOS in Q3 2021 and held it in 5 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of VVOS: Royce & Associates LP, Walleye Capital LLC, Two Sigma Investments, LP